Sutro Biopharma Inc. (NASDAQ: STRO)
$4.15
-0.0750 ( -1.78% ) 776.2K
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.
Market Data
Open
$4.15
Previous close
$4.22
Volume
776.2K
Market cap
$339.04M
Day range
$4.00 - $4.35
52 week range
$2.01 - $6.13
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
10-q | Quarterly Reports | 78 | Nov 13, 2023 |
8-k | 8K-related | 14 | Nov 13, 2023 |
8-k | 8K-related | 12 | Oct 04, 2023 |
4 | Insider transactions | 1 | Sep 19, 2023 |
3 | Insider transactions | 2 | Sep 19, 2023 |
4 | Insider transactions | 1 | Aug 29, 2023 |
4 | Insider transactions | 1 | Aug 28, 2023 |
4 | Insider transactions | 1 | Aug 11, 2023 |
8-k | 8K-related | 14 | Aug 10, 2023 |
10-q | Quarterly Reports | 78 | Aug 10, 2023 |